Chapter 1. Prefix
     1.1. Market Scope
     1.2. Report Description
     1.3. Research Methodology
           1.3.1 Primary Research
           1.3.2 Secondary Research
           1.3.3 In-house Data Modeling
Chapter 2. Executive Summary
Chapter 3. Market Outline
     3.1 Market Inclination, Trend, Outlook and Viewpoint
     3.2 Market Share Analysis: Company’s Competitive Scenario
     3.3 Value Chain Analysis
     3.4 Market Dynamics
            3.4.1 Drivers
                 3.4.1.1 Impact Analysis
           3.4.2. Restraints
                 3.4.2.1 Impact Analysis
           3.4.3 Opportunities
     3.5 Porter’s five forces analysis
           3.5.1 Factors Impact Analysis
Chapter 4. Depression Drug Market by Type: Market Size and Forecast, 2015 – 2024
     4.1 Anticonvulsants
     4.2 Serotonin-norepinephrine reuptake inhibitors (SNRIs)
     4.3 Beta-blockers
     4.4 Benzodiazepines
     4.5 Tetracyclic antidepressants (TeCAs)
     4.6 Selective serotonin reuptake inhibitors (SSRIs)
     4.7 Monoamine oxidase inhibitors (MAOIs)
Chapter 5. Depression Drug Market by Application: Market Size and Forecast, 2015 – 2024
     5.1 Clinics and Hospitals
     5.2 Research Centers
Chapter 6. Depression Drug Market by Geography: Market Size and Forecast, 2015 – 2024
     6.1 North America
           6.1.1 U.S.
           6.1.2 Canada
           6.1.3 Mexico
     6.2 Europe
           6.2.1 UK
           6.2.1 Germany
           6.2.2 France
           6.2.4 Rest of Europe
     6.3 Asia-Pacific
           6.3.1 China
           6.3.2 Japan
           6.3.3 India
           6.3.4 Australia
           6.3.5 Rest of Asia-Pacific
     6.4 Rest of the World
           6.4.1 South America
           6.4.2 The Middle East
           6.4.3 Africa
Chapter 7. Company Profiles
     7.1 H.Lundbeck, Merck & Co.
     7.2 SK Biopharmaceuticals
     7.3 Novartis
     7.4 AstraZeneca
     7.5 Forest Laboratories
     7.6 Naurex
     7.7 GlaxoSmithKline
     7.8 Eli Lilly and Co.

Related Report
Treatment for Syndromes of Dementia and Movement Disorders Market (By Type: Movement Disorders, Progressive Dementia, and Progressive Dementia with Neurological Abnormalities; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend, and Forecast, 2015-2024
Biological Drugs Market (By Product Type: Therapeutic Protein, Monoclonal Antibody, and Vaccine; By Geography: North America, Europe, Asia-Pacific, and RoW) Global Scenario, Market Size, Outlook, Trend, and Forecast, 2015-2024
Diabetic Nephropathy Market (By Mode of Treatment: Drug Modifying Therapies, and Others; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024
Cleanroom Technology Market (By Type: Equipment And Consumables; By Construction: Standard/Drywall Cleanrooms, Hardwall Cleanrooms, Softwall Cleanrooms And Terminal Boxes/Pass Through Cabinets; By Application: Biotechnology, Pharmaceuticals, Medical Devices And Others; By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend, and Forecast, 2015-2024
Membrane Technology in Pharma, Biopharma, And Life Science Market (By Application: Pharmaceuticals, Biopharmaceuticals, And Life Sciences; By Technology: Ultrafiltration, Microfiltration, Nanofiltration, Chromatography; North America, Europe, Asia-Pacific, and RoW) Global Scenario, Market Size, Outlook, Trend, and Forecast, 2015-2024